Circulation of influenza A and B in the Czech Republic from 2000-2001 to 2015-2016
- PMID: 30764763
- PMCID: PMC6376715
- DOI: 10.1186/s12879-019-3783-z
Circulation of influenza A and B in the Czech Republic from 2000-2001 to 2015-2016
Abstract
Background: To improve national influenza vaccination recommendations, additional data on influenza A and B virus circulation are needed. Here, we describe the circulation of influenza A and B in the Czech Republic during 16 seasons.
Methods: This was a retrospective analysis of data collected from the 2000-2001 to 2015-2016 influenza seasons by the Czech Republic national influenza surveillance network. Influenza was confirmed and viral isolates subtyped by virological assays followed by antigen detection or by reverse transcriptase-polymerase chain reaction.
Results: Of 16,940 samples collected, 5144 (30.4%) were influenza-positive. Influenza A represented 78.6% of positive cases overall and accounted for more than 55.0% of all influenza cases in every season, except for 2005-2006 (6.0%). Both A/H1N1 and A/H3N2 were detected in most seasons, except for 2001-2002 and 2003-2004 (only A/H3N2), and 2007-2008 and 2009-2010 (only A/H1N1). Influenza B represented 21.4% of positive cases overall (range, 0.0-94.0% per season). Both influenza B lineages were detected in three seasons, a single B lineage in 11, and no B strain in two. For the 11 seasons where influenza B accounted for ≥20% of positive cases, the dominant lineage was Yamagata in six and Victoria in four. In the remaining season, the two lineages co-circulated. For two seasons (2005-2006 and 2007-2008), the B lineage in the trivalent influenza vaccine did not match the dominant circulating B lineage.
Conclusions: In the Czech Republic, during the 2000-2001 to 2015-2016 influenza seasons, influenza virus circulation varied considerably. Although influenza A accounted for the most cases in almost all seasons, influenza B made a substantial, sometimes dominant, contribution to influenza disease.
Keywords: Czech Republic; Epidemiology; Influenza A; Influenza B; Influenza surveillance; Lineage.
Conflict of interest statement
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
SD and AR are employees of Sanofi Pasteur. The remaining authors declare no competing interests. The National Institute of Public Health in Prague is partner of the Global Influenza Hospital Surveillance Network (GIHSN) and received support for this study from the Foundation for Influenza Epidemiology, partly funded by Sanofi Pasteur, and under the auspices of Fondation de France. JK is the national project coordinator of the GIHSN for the Czech Republic. Sanofi Pasteur also funded the medical writing support for the preparation and submission of the manuscript to the journal.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
References
-
- Council of the European Union Council Recommendation of 22 December 2009 on seasonal influenza vaccination. Off J Eur. Union. 2009;L 348:71–72.
-
- Recommended procedure for vaccination against seasonal influenza in the Czech Republic [article in Czech]. Ministry of Health of the Czech Republic; 2011. http://www.mzcr.cz/dokumenty/doporuceny-postup-pro-ockovani-proti-sezonn.... Accessed 23 Jan 2017.
-
- European Centre for Disease Prevention and Control. Seasonal influenza vaccination in Europe. Overview of vaccination recommendations and coverage rates in the EU Member States for the 2012–13 influenza season. ECDC; 2015. https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publicat.... Accessed 28 Sept 2016.
-
- Prevention and control of influenza pandemics and annual epidemics. Resolution WHA56.19 of 28 May 2003. Geneva: World Health Organization; 2003. http://www.who.int/immunization/sage/1_WHA56_19_Prevention_and_control_o.... Accessed 9 Aug 2017.
-
- Seasonal influenza vaccination programme, country profile: Czech Republic, 2012–2013 Season. European Centre for Disease Control and Prevention, Stockholm, Sweden. https://ecdc.europa.eu/sites/portal/files/media/en/publications/Report%2... (2015). Accessed 16 Jun 2016.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
